Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG-Study Group

Transplant Proc. 1993 Oct;25(5 Suppl 4):22-4.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Cytomegalovirus Infections / therapy*
  • Double-Blind Method
  • Ganciclovir / therapeutic use*
  • Humans
  • Immunization, Passive
  • Liver Transplantation*
  • Pneumonia / therapy*
  • Prospective Studies
  • Risk Factors

Substances

  • Ganciclovir